RETRACTED: Novel insights into rosacea's role in cancer risk: A Mendelian randomization approach
Authors:
Open Access
- 20 May 2024
- journal article
- retracted article
- Published by Wiley in Skin Research and Technology
- Vol. 30 (5) , e13737
Abstract
Background: Chronic inflammation has been shown to promote cancer progression. Rosacea is indeed a long‐term inflammatory skin condition and had been reported to link with increased risk for several types of malignancies, but evidence for causality is lacking. Objectives: To systematically estimate the causal relationship between rosacea and several types of cancer, including cutaneous malignant melanoma (CMM), cutaneous squamous cell carcinoma (cSCC), basal cell carcinoma (BCC), actinic keratosis (AK), thyroid cancer, breast cancer, glioma and hepatic cancer, as well as explore the potential underlying pathogenesis. Methods: We conducted a bidirectional two‐sample Mendelian randomization study to probe the potential causal relationships between rosacea and several types of cancer. Instrumental variables were established using genome‐wide significant single nucleotide polymorphisms associated with rosacea and cancers. The assessment of causality was carried out through multiple methods, and the robustness of the results was evaluated via sensitivity analyses. Results: There was no significant indication of causal effects of rosacea on CMM ( p ivw = 0.71), cSCC ( p ivw = 0.45), BCC ( p ivw = 0.90), AK ( p ivw = 0.73), thyroid cancer ( p ivw = 0.59), glioma ( p ivw = 0.15), and hepatic cancer ( p ivw = 0.07), but the genetic risk of rosacea was associated with an increased susceptibility to human epidermal growth factor receptor (HER)‐negative malignant neoplasm of breast (odds ratio [OR], 1.10; 95% confidence interval [CI], 1.02–1.18; p ivw = 0.01). TANK (TRAF family member associated nuclear factor kappa B (NFKB) activator) was identified as a common protective gene for both rosacea (OR, 0.90; 95% CI, 0.82–0.99; p ivw = 0.048) and HER‐negative malignant neoplasm of the breast (OR, 0.86; 95% CI, 0.75–0.98; p ivw = 0.032), which was primarily enriched in the negative regulation of NF‐κB signal transduction and may contribute to the genetic links between rosacea and this subtype of breast cancer. Conclusions: Our findings provide suggestive evidence for causal links between rosacea and HER‐negative malignant neoplasm of the breast risk.Keywords
This publication has 32 references indexed in Scilit:
- Rosacea: Molecular Mechanisms and Management of a Chronic Cutaneous Inflammatory ConditionInternational Journal of Molecular Sciences, 2016
- Encephalomyocarditis Virus 3C Protease Relieves TRAF Family Member-associated NF-κB Activator (TANK) Inhibitory Effect on TRAF6-mediated NF-κB Signaling through Cleavage of TANKJournal of Biological Chemistry, 2015
- Personal history of rosacea and risk of incident cancer among women in the USBritish Journal of Cancer, 2015
- TRAF Family Member-associated NF-κB Activator (TANK) Inhibits Genotoxic Nuclear Factor κB Activation by Facilitating Deubiquitinase USP10-dependent Deubiquitination of TRAF6 LigaseJournal of Biological Chemistry, 2015
- Ubiquitin-mediated modulation of the cytoplasmic viral RNA sensor RIG-IThe Journal of Biochemistry, 2011
- Immune Signaling by RIG-I-like ReceptorsImmunity, 2011
- TANK is a negative regulator of Toll-like receptor signaling and is critical for the prevention of autoimmune nephritisNature Immunology, 2009
- Identification and Characterization of MAVS, a Mitochondrial Antiviral Signaling Protein that Activates NF-κB and IRF3Cell, 2005
- NF‐κB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK‐related kinaseThe EMBO Journal, 1999
- Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein.Proceedings of the National Academy of Sciences, 1996